Please Wait.....
Report
Dermal Filler Market By Type (Hyaluronic acid (HA), Calcium Hydroxylapatite (CaHA), Poly L lactic Acid, Others), By Gender (Male, Female), By Service Provider (Specialty and Dermatology Clinics, Hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-10-01 I 250 Pages I Allied Market Research
The global dermal filler market was valued at $5,184.8 million in 2021, and is projected to reach $14,418.4 million by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal filler is defined as an aesthetic procedure, which is injected beneath the surface of the skin to add fullness & volume, smooth lines & soften creases, and increase the facial contours. It is widely used for facial aesthetic treatment. The different types of dermal filler are hyaluronic acid, calcium hydroxylapatite, polylactic acid, and polymethyl-methacrylate microspheres. It is used to enhance or fill the shallow areas on the face. In addition, this procedure is mostly used among population to reduce wrinkle under eyes.
The growth of the global dermal filler market is majorly driven by an alarming increase in demand for minimally invasive procedure; rise in government initiative for the advancement of dermal filler procedure; surge in the number of approvals for dermal filler' products; and a rise in adoption of hyaluronic acid. According to the journal of Dermatology & Mohs Surgery Institute, it was analyzed that dermal filler is one of the leading minimally invasive skin procedure, globally. For instance, in 2021, Deloitte, one of the leading professional services companies, reported that around 9.53% of hyaluronic acid is consumed in China. Thus, the increase in prevalence of hyaluronic acid boosts the demand for dermal filler procedure.
Moreover, in 2021, the U.S. Food and drug Administration (FDA) announced the approval of RHA Redensity Dermal Filler, which is used for the treatment of moderate to severe dynamic perioral rhytids (lip lines) in the adults above the age of 22. Furthermore, in 2021, Revance Therapeutics, Inc., a biotechnology company, presented data on the effectiveness and safety of the RHA collection of dermal filler. It is one of the latest advances in hyaluronic acid filler technology, which is used for the treatment of moderate-to-severe nasolabial folds in darker skin color. The increase in advancements in dermal filler technology aims to obtain long-lasting, and effective results. Thus, advancements in technology for advanced dermal filler products in emerging nations are expected to propel the growth of the market.
The increase in government support for aesthetic procedure and surge in demand for aesthetic procedure are the major factors that drive the global dermal filler market. For instance, in February 2022, the GOV.UK announced to introduce a licensing regime for non-surgical cosmetic procedures such as dermal filler and Botox. This step aims to protect the public against botch fillers and botox. In addition, increase in the number of anti-aging treatment significantly contributes toward the market growth. Rise in demand for aesthetic looks among young population acts a key driving force for the expansion of the global market.
However, the high cost associated with dermal filler procedure is anticipated to hinder the market growth. Increase in prevalence of early skin aging, surge the need for hyaluronic acid and drive the growth of the market. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the dermal filler market.
The dermal filler market is segmented into type, gender, service provider, and region. By type, the market is categorized into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. By gender, it is bifurcated into male and female. By service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global dermal filler market are include AbbVie Laboratories, Bioxis pharmaceutical, Cutera Inc., Elan aesthetics Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermal filler market analysis from 2021 to 2031 to identify the prevailing dermal filler market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the dermal filler market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global dermal filler market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Hyaluronic acid (HA)
- Age group
- 13 to 39
- 40 to 54
- 55 to 69
- Calcium Hydroxylapatite (CaHA)
- Poly L lactic Acid
- Others
By Gender
- Male
- Female
By Service Provider
- Specialty and Dermatology Clinics
- Hospitals
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest Of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- Colombia
- Rest Of LAMEA
- Key Market Players
- AbbVie Laboratories
- Bioxis pharmaceutical
- Cutera Inc
- Elan aesthetics Inc
- Galderma SA
- Merz Pharma GmbH and Co. KGaA
- Revance Therapeutics
- Sinclair Pharma
- Teoxane Laboratories
- Vital Esthetique Laboratories
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Patent Landscape
CHAPTER 4: DERMAL FILLER MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Hyaluronic acid (HA)
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Hyaluronic acid (HA) Dermal Filler Market by Age group
4.2.4.1 13 to 39 Market size and forecast, by region
4.2.4.2 40 to 54 Market size and forecast, by region
4.2.4.3 55 to 69 Market size and forecast, by region
4.3 Calcium Hydroxylapatite (CaHA)
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Poly L lactic Acid
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Others
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: DERMAL FILLER MARKET, BY GENDER
5.1 Overview
5.1.1 Market size and forecast
5.2 Male
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Female
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER
6.1 Overview
6.1.1 Market size and forecast
6.2 Specialty and Dermatology Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Hospitals
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: DERMAL FILLER MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.2.1 North America Hyaluronic acid (HA) Dermal Filler Market by Age group
7.2.3 North America Market size and forecast, by Gender
7.2.4 North America Market size and forecast, by Service Provider
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Gender
7.2.5.1.3 Market size and forecast, by Service Provider
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Gender
7.2.5.2.3 Market size and forecast, by Service Provider
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Gender
7.2.5.3.3 Market size and forecast, by Service Provider
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.2.1 Europe Hyaluronic acid (HA) Dermal Filler Market by Age group
7.3.3 Europe Market size and forecast, by Gender
7.3.4 Europe Market size and forecast, by Service Provider
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Gender
7.3.5.1.3 Market size and forecast, by Service Provider
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Gender
7.3.5.2.3 Market size and forecast, by Service Provider
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Gender
7.3.5.3.3 Market size and forecast, by Service Provider
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Gender
7.3.5.4.3 Market size and forecast, by Service Provider
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Gender
7.3.5.5.3 Market size and forecast, by Service Provider
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Gender
7.3.5.6.3 Market size and forecast, by Service Provider
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.2.1 Asia-Pacific Hyaluronic acid (HA) Dermal Filler Market by Age group
7.4.3 Asia-Pacific Market size and forecast, by Gender
7.4.4 Asia-Pacific Market size and forecast, by Service Provider
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Gender
7.4.5.1.3 Market size and forecast, by Service Provider
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Gender
7.4.5.2.3 Market size and forecast, by Service Provider
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Gender
7.4.5.3.3 Market size and forecast, by Service Provider
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Gender
7.4.5.4.3 Market size and forecast, by Service Provider
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Gender
7.4.5.5.3 Market size and forecast, by Service Provider
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.2.1 LAMEA Hyaluronic acid (HA) Dermal Filler Market by Age group
7.5.3 LAMEA Market size and forecast, by Gender
7.5.4 LAMEA Market size and forecast, by Service Provider
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Gender
7.5.5.1.3 Market size and forecast, by Service Provider
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Gender
7.5.5.2.3 Market size and forecast, by Service Provider
7.5.5.3 Colombia
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Gender
7.5.5.3.3 Market size and forecast, by Service Provider
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Gender
7.5.5.4.3 Market size and forecast, by Service Provider
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 AbbVie Laboratories
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Bioxis pharmaceutical
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Cutera Inc
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Elan aesthetics Inc
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Galderma SA
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Merz Pharma GmbH and Co. KGaA
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Revance Therapeutics
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Sinclair Pharma
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Teoxane Laboratories
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Vital Esthetique Laboratories
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 2. DERMAL FILLER MARKET, FOR HYALURONIC ACID (HA), BY REGION, 2021-2031 ($MILLION)
TABLE 3. DERMAL FILLER MARKET FOR HYALURONIC ACID (HA), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. GLOBAL HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 5. DERMAL FILLER MARKET, FOR 13 TO 39, BY REGION, 2021-2031 ($MILLION)
TABLE 6. DERMAL FILLER MARKET, FOR 40 TO 54, BY REGION, 2021-2031 ($MILLION)
TABLE 7. DERMAL FILLER MARKET, FOR 55 TO 69, BY REGION, 2021-2031 ($MILLION)
TABLE 8. DERMAL FILLER MARKET, FOR CALCIUM HYDROXYLAPATITE (CAHA), BY REGION, 2021-2031 ($MILLION)
TABLE 9. DERMAL FILLER MARKET FOR CALCIUM HYDROXYLAPATITE (CAHA), BY COUNTRY, 2021-2031 ($MILLION)
TABLE 10. DERMAL FILLER MARKET, FOR POLY L LACTIC ACID, BY REGION, 2021-2031 ($MILLION)
TABLE 11. DERMAL FILLER MARKET FOR POLY L LACTIC ACID, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 12. DERMAL FILLER MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. DERMAL FILLER MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. GLOBAL DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 15. DERMAL FILLER MARKET, FOR MALE, BY REGION, 2021-2031 ($MILLION)
TABLE 16. DERMAL FILLER MARKET FOR MALE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 17. DERMAL FILLER MARKET, FOR FEMALE, BY REGION, 2021-2031 ($MILLION)
TABLE 18. DERMAL FILLER MARKET FOR FEMALE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. GLOBAL DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 20. DERMAL FILLER MARKET, FOR SPECIALTY AND DERMATOLOGY CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 21. DERMAL FILLER MARKET FOR SPECIALTY AND DERMATOLOGY CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. DERMAL FILLER MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 23. DERMAL FILLER MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. DERMAL FILLER MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 25. DERMAL FILLER MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. DERMAL FILLER MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 29. NORTH AMERICA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 31. NORTH AMERICA DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. U.S. DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 33. U.S. DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 34. U.S. DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 35. CANADA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 36. CANADA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 37. CANADA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 38. MEXICO DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 39. MEXICO DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 40. MEXICO DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 41. EUROPE DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 42. EUROPE HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 43. EUROPE DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 44. EUROPE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 45. EUROPE DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 46. GERMANY DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 47. GERMANY DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 48. GERMANY DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 49. FRANCE DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 50. FRANCE DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 51. FRANCE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 52. UK DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 53. UK DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 54. UK DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 55. ITALY DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 56. ITALY DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 57. ITALY DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 58. SPAIN DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 59. SPAIN DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 60. SPAIN DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 69. CHINA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 70. CHINA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 71. CHINA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 72. JAPAN DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 73. JAPAN DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 74. JAPAN DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 75. INDIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 76. INDIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 77. INDIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 80. AUSTRALIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 81. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 82. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 83. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 84. LAMEA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 85. LAMEA HYALURONIC ACID (HA) DERMAL FILLER MARKET, BY AGE GROUP, 2021-2031 ($MILLION)
TABLE 86. LAMEA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 87. LAMEA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 88. LAMEA DERMAL FILLER MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 89. BRAZIL DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 90. BRAZIL DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 91. BRAZIL DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 92. SAUDI ARABIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 93. SAUDI ARABIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 94. SAUDI ARABIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 95. COLOMBIA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 96. COLOMBIA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 97. COLOMBIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 98. REST OF LAMEA DERMAL FILLER MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 99. REST OF LAMEA DERMAL FILLER MARKET, BY GENDER, 2021-2031 ($MILLION)
TABLE 100. REST OF LAMEA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2021-2031 ($MILLION)
TABLE 101.ABBVIE LABORATORIES: COMPANY SNAPSHOT
TABLE 102.ABBVIE LABORATORIES: OPERATING SEGMENTS
TABLE 103.ABBVIE LABORATORIES: PRODUCT PORTFOLIO
TABLE 104.ABBVIE LABORATORIES: NET SALES,
TABLE 105.ABBVIE LABORATORIES: KEY STRATERGIES
TABLE 106.BIOXIS PHARMACEUTICAL: COMPANY SNAPSHOT
TABLE 107.BIOXIS PHARMACEUTICAL: OPERATING SEGMENTS
TABLE 108.BIOXIS PHARMACEUTICAL: PRODUCT PORTFOLIO
TABLE 109.BIOXIS PHARMACEUTICAL: NET SALES,
TABLE 110.BIOXIS PHARMACEUTICAL: KEY STRATERGIES
TABLE 111.CUTERA INC: COMPANY SNAPSHOT
TABLE 112.CUTERA INC: OPERATING SEGMENTS
TABLE 113.CUTERA INC: PRODUCT PORTFOLIO
TABLE 114.CUTERA INC: NET SALES,
TABLE 115.CUTERA INC: KEY STRATERGIES
TABLE 116.ELAN AESTHETICS INC: COMPANY SNAPSHOT
TABLE 117.ELAN AESTHETICS INC: OPERATING SEGMENTS
TABLE 118.ELAN AESTHETICS INC: PRODUCT PORTFOLIO
TABLE 119.ELAN AESTHETICS INC: NET SALES,
TABLE 120.ELAN AESTHETICS INC: KEY STRATERGIES
TABLE 121.GALDERMA SA: COMPANY SNAPSHOT
TABLE 122.GALDERMA SA: OPERATING SEGMENTS
TABLE 123.GALDERMA SA: PRODUCT PORTFOLIO
TABLE 124.GALDERMA SA: NET SALES,
TABLE 125.GALDERMA SA: KEY STRATERGIES
TABLE 126.MERZ PHARMA GMBH AND CO. KGAA: COMPANY SNAPSHOT
TABLE 127.MERZ PHARMA GMBH AND CO. KGAA: OPERATING SEGMENTS
TABLE 128.MERZ PHARMA GMBH AND CO. KGAA: PRODUCT PORTFOLIO
TABLE 129.MERZ PHARMA GMBH AND CO. KGAA: NET SALES,
TABLE 130.MERZ PHARMA GMBH AND CO. KGAA: KEY STRATERGIES
TABLE 131.REVANCE THERAPEUTICS: COMPANY SNAPSHOT
TABLE 132.REVANCE THERAPEUTICS: OPERATING SEGMENTS
TABLE 133.REVANCE THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 134.REVANCE THERAPEUTICS: NET SALES,
TABLE 135.REVANCE THERAPEUTICS: KEY STRATERGIES
TABLE 136.SINCLAIR PHARMA: COMPANY SNAPSHOT
TABLE 137.SINCLAIR PHARMA: OPERATING SEGMENTS
TABLE 138.SINCLAIR PHARMA: PRODUCT PORTFOLIO
TABLE 139.SINCLAIR PHARMA: NET SALES,
TABLE 140.SINCLAIR PHARMA: KEY STRATERGIES
TABLE 141.TEOXANE LABORATORIES: COMPANY SNAPSHOT
TABLE 142.TEOXANE LABORATORIES: OPERATING SEGMENTS
TABLE 143.TEOXANE LABORATORIES: PRODUCT PORTFOLIO
TABLE 144.TEOXANE LABORATORIES: NET SALES,
TABLE 145.TEOXANE LABORATORIES: KEY STRATERGIES
TABLE 146.VITAL ESTHETIQUE LABORATORIES: COMPANY SNAPSHOT
TABLE 147.VITAL ESTHETIQUE LABORATORIES: OPERATING SEGMENTS
TABLE 148.VITAL ESTHETIQUE LABORATORIES: PRODUCT PORTFOLIO
TABLE 149.VITAL ESTHETIQUE LABORATORIES: NET SALES,
TABLE 150.VITAL ESTHETIQUE LABORATORIES: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.DERMAL FILLER MARKET SEGMENTATION
FIGURE 2.DERMAL FILLER MARKET,2021-2031
FIGURE 3.DERMAL FILLER MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.DERMAL FILLER MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.PATENT ANALYSIS BY COMPANY
FIGURE 13.PATENT ANALYSIS BY COUNTRY
FIGURE 14.DERMAL FILLER MARKET,BY TYPE,2021(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF HYALURONIC ACID (HA) DERMAL FILLER MARKET,2021-2031(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CALCIUM HYDROXYLAPATITE (CAHA) DERMAL FILLER MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF POLY L LACTIC ACID DERMAL FILLER MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS DERMAL FILLER MARKET,2021-2031(%)
FIGURE 19.DERMAL FILLER MARKET,BY GENDER,2021(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MALE DERMAL FILLER MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF FEMALE DERMAL FILLER MARKET,2021-2031(%)
FIGURE 22.DERMAL FILLER MARKET,BY SERVICE PROVIDER,2021(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF SPECIALTY AND DERMATOLOGY CLINICS DERMAL FILLER MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF HOSPITALS DERMAL FILLER MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS DERMAL FILLER MARKET,2021-2031(%)
FIGURE 26.DERMAL FILLER MARKET BY REGION,2021
FIGURE 27.U.S. DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 28.CANADA DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 29.MEXICO DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 30.GERMANY DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 31.FRANCE DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 32.UK DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 33.ITALY DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 34.SPAIN DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 35.REST OF EUROPE DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 36.CHINA DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 37.JAPAN DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 38.INDIA DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 39.AUSTRALIA DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 40.REST OF ASIA-PACIFIC DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 41.BRAZIL DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 42.SAUDI ARABIA DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 43.COLOMBIA DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 44.REST OF LAMEA DERMAL FILLER MARKET,2021-2031($MILLION)
FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 49.COMPETITIVE DASHBOARD
FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 51.ABBVIE LABORATORIES.: NET SALES ,($MILLION)
FIGURE 52.BIOXIS PHARMACEUTICAL.: NET SALES ,($MILLION)
FIGURE 53.CUTERA INC.: NET SALES ,($MILLION)
FIGURE 54.ELAN AESTHETICS INC.: NET SALES ,($MILLION)
FIGURE 55.GALDERMA SA.: NET SALES ,($MILLION)
FIGURE 56.MERZ PHARMA GMBH AND CO. KGAA.: NET SALES ,($MILLION)
FIGURE 57.REVANCE THERAPEUTICS.: NET SALES ,($MILLION)
FIGURE 58.SINCLAIR PHARMA.: NET SALES ,($MILLION)
FIGURE 59.TEOXANE LABORATORIES.: NET SALES ,($MILLION)
FIGURE 60.VITAL ESTHETIQUE LABORATORIES.: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security